Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed-dose versus weight-based amikacin for urinary tract infection in older adults
MOH_2019-12-18_008556Phase 4Not yet recruiting
- Sponsor
- יוחאי לוי
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amikacin in urinary tract infection (UTI) (2 arms), sponsored by יוחאי לוי. Primary endpoint: Clinical outcomes of fixed-dose amikacin. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
amikacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on MOH_2019-12-18_008556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-12-18_008556.